Jext (Epinephrine Bitartrate)

Epinephrine stimulates α1‑adrenergic receptors to cause vasoconstriction, which raises systemic vascular resistance and blood pressure. It also activates β1 receptors, increasing heart rate and contractility, and β2 receptors, which relax bronchial smooth muscle and inhibit mast‑cell mediator release. Together these actions quickly counteract the physiological cascade of anaphylaxis.

The dose of Jext is determined by the prescribing healthcare professional based on the patient’s age, weight, and clinical situation. The auto‑injector contains a fixed amount of epinephrine that is administered as a single intramuscular injection during an emergency, and the prescriber decides the appropriate device strength for each patient.

Data on epinephrine use in pregnancy and lactation are limited. The drug should be used only if the potential benefit outweighs any possible risk to the fetus or infant. Healthcare providers typically consider the urgent need to treat anaphylaxis as a justification for use, but the decision must be individualized.

To order Jext, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Jext contains epinephrine Bitartrate in a single‑use auto‑injector designed for rapid intramuscular delivery, similar to other market‑available epinephrine devices. Differences may lie in device ergonomics, needle length, and regulatory approvals. Clinically, all approved epinephrine auto‑injectors provide comparable pharmacologic effects; selection often depends on regional availability, prescribing habits, and patient preference.

Jext should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. The device must not be exposed to extreme temperatures or mechanical shock. Do not refrigerate or freeze the auto‑injector. Check the expiration date regularly and replace any unit that is past its shelf‑life.

Jext is administered by pressing the auto‑injector firmly against the outer thigh, preferably through clothing, and holding it in place for the recommended time (usually about 3 seconds). The needle then penetrates the muscle, delivering the epinephrine dose intramuscularly. After injection, seek immediate medical attention for further evaluation and care.

Serious risks include cardiac arrhythmias, severe hypertension, myocardial ischemia, and cerebral hemorrhage, especially in patients with underlying heart disease. Rapid cardiovascular changes can occur, so monitoring after administration is essential. Rarely, an allergic reaction to the epinephrine formulation itself may develop, requiring prompt medical assessment.

Jext is contraindicated in individuals with known hypersensitivity to epinephrine or any component of the auto‑injector. It should be used with caution in patients with certain cardiac conditions, uncontrolled hypertension, or hyperthyroidism, and only under medical guidance. Children and adults who are not at risk for severe allergic reactions should not use the device.